Crossref
journal-article
Elsevier BV
Biochemical and Biophysical Research Communications (78)
References
111
Referenced
116
10.2174/1566524023362474
/ Curr. Mol. Med. / The promise and obstacle of p53 as a cancer therapeutic agent by Willis (2002)10.4161/cbt.210
/ Cancer Biol. Ther. / Tumor-suppressing gene therapy by Fang (2003)10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3
/ J. Pathol. / The p53 pathway by Prives (1999)10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G
/ Hum. Mutat. / p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis by Soussi (2000)10.1006/excr.2000.5141
/ Exp. Cell Res. / Regulation of p53 function by Woods (2001)10.1038/35094077
/ Nat. Rev. Cancer / Rescuing the function of mutant p53 by Bullock (2001)10.1016/S0959-8049(03)00063-7
/ Eur. J. Cancer / Improving cancer therapy by non-genotoxic activation of p53 by Lain (2003)10.1093/emboj/16.6.1391
/ EMBO J. / Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo by Komarova (1997)-
S. Lowe, E. Schmitt, S. Smith, B. Osborne, T. Jacks, Nature, 1993 pp. 847–849
(
10.1038/362847a0
) {'key': '10.1016/j.bbrc.2005.03.153_bib10', 'first-page': '159', 'article-title': 'Apoptosis in bone marrow cells of mice with different p53 genotypes after γ-rays irradiation in vitro', 'volume': '14', 'author': 'Cui', 'year': '1995', 'journal-title': 'J. Environ. Pathol. Toxicol. Oncol.'}
/ J. Environ. Pathol. Toxicol. Oncol. / Apoptosis in bone marrow cells of mice with different p53 genotypes after γ-rays irradiation in vitro by Cui (1995)10.2307/3579455
/ Radiat. Res. / Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice by Wang (1996)10.1016/S0002-9440(10)65215-7
/ Am. J. Pathol. / Different responses of epidermal and hair follicular cells to radiation correlate with distinct patterns of p53 and p21 induction by Song (1999)10.1038/sj.cdd.4400704
/ Cell Death Differ. / Radiation-induced apoptosis in the adult central nervous system is p53-dependent by Chow (2000){'key': '10.1016/j.bbrc.2005.03.153_bib14', 'first-page': '614', 'article-title': 'The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice', 'volume': '54', 'author': 'Merritt', 'year': '1994', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice by Merritt (1994)10.1038/ng0897-397
/ Nat. Genet. / Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity by Westphal (1997)10.1006/scbi.1998.0101
/ Semin. Cancer Biol. / Could p53 be a target for therapeutic suppression? by Komarova (1998)10.1016/S0006-2952(01)00733-X
/ Biochem. Pharmacol. / Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors by Komarova (2001)10.1038/nrc992
/ Nat. Rev. Cancer / The role of p53 in determining sensitivity to radiotherapy by Gudkov (2003){'key': '10.1016/j.bbrc.2005.03.153_bib19', 'first-page': '71', 'article-title': 'Genetic alterations associated with bladder cancer', 'author': 'Cordon-Cardo', 'year': '1994', 'journal-title': 'Important Adv. Oncol.'}
/ Important Adv. Oncol. / Genetic alterations associated with bladder cancer by Cordon-Cardo (1994){'key': '10.1016/j.bbrc.2005.03.153_bib20', 'first-page': '1451', 'article-title': 'Prognostic value of P53 gene mutations in a large series of node- negative breast cancer patients', 'volume': '58', 'author': 'Falette', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Prognostic value of P53 gene mutations in a large series of node- negative breast cancer patients by Falette (1998){'key': '10.1016/j.bbrc.2005.03.153_bib21', 'first-page': '507', 'article-title': 'p53 oncoprotein as a prognostic indicator in patients with breast cancer', 'volume': '18', 'author': 'Molina', 'year': '1998', 'journal-title': 'Anticancer Res.'}
/ Anticancer Res. / p53 oncoprotein as a prognostic indicator in patients with breast cancer by Molina (1998)10.1172/JCI6863
/ J. Clin. Invest. / Disruption of p53 in human cancer cells alters the responses to therapeutic agents by Bunz (1999)10.1054/drup.2001.0213
/ Drug Resist. Updat. / If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells by Roninson (2001){'key': '10.1016/j.bbrc.2005.03.153_bib24', 'first-page': '4164', 'article-title': 'Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage', 'volume': '53', 'author': 'Slichenmyer', 'year': '1993', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage by Slichenmyer (1993){'key': '10.1016/j.bbrc.2005.03.153_bib25', 'first-page': '3667', 'article-title': 'p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines', 'volume': '53', 'author': 'Brachman', 'year': '1993', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines by Brachman (1993)10.1053/ctrv.1999.0145
/ Cancer Treat. Rev. / The challenge of p53 as prognostic and predictive factor in gliomas by Nieder (2000)10.1006/bcmd.2000.0372
/ Blood Cells Mol. Dis. / Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo by Schmitt (2001)10.1038/379088a0
/ Nature / Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours by Graeber (1996)10.1002/jcb.10382
/ J. Cell Biochem. / Paradoxical role of apoptosis in cancer progression by Gurova (2003)10.4161/cbt.1.1.39
/ Cancer Biol. Ther. / Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor by Gurova (2002){'key': '10.1016/j.bbrc.2005.03.153_bib31', 'first-page': '1878', 'article-title': 'Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer', 'volume': '60', 'author': 'Browder', 'year': '2000', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer by Browder (2000)10.1038/sj.onc.1207494
/ Oncogene / Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury but protects from gastro-intestinal syndrome in mice by Komarova (2004)10.1126/science.285.5434.1733
/ Science / A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy by Komarov (1999)10.1074/jbc.M107442200
/ J. Biol. Chem. / Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism by Lorenzo (2002)10.1074/jbc.M400944200
/ J. Biol. Chem. / Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. Intermediacy of H(2)O(2)- and p53-dependent pathways by Wang (2004)10.1002/mc.10130
/ Mol. Carcinog. / Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells by Kaji (2003)10.1152/ajpheart.00759.2003
/ Am. J. Physiol. Heart Circ. Physiol. / Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice by Liu (2004)10.1016/S0306-4522(03)00286-0
/ Neuroscience / Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis by Zhang (2003)10.1152/ajprenal.00262.2004
/ Am. J. Physiol. Renal Physiol. / Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity by Jiang (2004)10.1023/A:1006933312401
/ Cell. Mol. Neurobiol. / The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53 by Daily (1999)10.1016/S0006-8993(96)01358-3
/ Brain Res / p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cells by Blum (1997){'key': '10.1016/j.bbrc.2005.03.153_bib42', 'first-page': 'v', 'article-title': 'A role for the tumour suppressor gene p53 in regulating neuronal apoptosis', 'volume': '8', 'author': 'Hughes', 'year': '1997', 'journal-title': 'Neuroreport'}
/ Neuroreport / A role for the tumour suppressor gene p53 in regulating neuronal apoptosis by Hughes (1997)10.1006/exnr.1997.6451
/ Exp. Neurol. / Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment by Sakhi (1997)10.1046/j.1460-9568.1998.00042.x
/ Eur J. Neurosci. / Induction of tumour-suppressor phosphoprotein p53 in the apoptosis of cultured rat cerebellar neurones triggered by excitatory amino acids by Uberti (1998)10.1523/JNEUROSCI.19-18-07860.1999
/ J. Neurosci. / Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons by Cregan (1999)10.1002/(SICI)1097-4547(20000515)60:4<450::AID-JNR3>3.0.CO;2-P
/ J. Neurosci. Res. / Role of p53 in DNA strand break-induced apoptosis in organotypic slice culture from the mouse cerebellum by Inamura (2000)10.1002/(SICI)1097-4547(19981215)54:6<721::AID-JNR1>3.0.CO;2-1
/ J. Neurosci. Res, / Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons by Johnson (1998)10.1523/JNEUROSCI.17-04-01397.1997
/ J. Neurosci. / p53 expression induces apoptosis in hippocampal pyramidal neuron cultures by Jordan (1997){'key': '10.1016/j.bbrc.2005.03.153_bib49', 'first-page': '125', 'article-title': 'DNA topoisomerase II poisons and inhibitors', 'volume': '18', 'author': 'Capranico', 'year': '1999', 'journal-title': 'Cancer Chemother. Biol. Response Modif.'}
/ Cancer Chemother. Biol. Response Modif. / DNA topoisomerase II poisons and inhibitors by Capranico (1999){'key': '10.1016/j.bbrc.2005.03.153_bib50', 'first-page': '81', 'article-title': 'DNA topoisomerase I poisons', 'volume': '18', 'author': 'Takimoto', 'year': '1999', 'journal-title': 'Cancer Chemother. Biol. Response Modif.'}
/ Cancer Chemother. Biol. Response Modif. / DNA topoisomerase I poisons by Takimoto (1999)10.1016/S0006-8993(98)00286-8
/ Brain Res. / Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death by Banasiak (1998)10.1016/0896-6273(93)90315-I
/ Neuron / Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein by Mattson (1993){'key': '10.1016/j.bbrc.2005.03.153_bib53', 'first-page': '401', 'article-title': 'P53- and CD95-associated apoptosis in neurodegenerative diseases', 'volume': '78', 'author': 'de la Monte', 'year': '1998', 'journal-title': 'Lab. Invest.'}
/ Lab. Invest. / P53- and CD95-associated apoptosis in neurodegenerative diseases by de la Monte (1998)10.1002/ana.410440712
/ Ann. Neurol. / Understanding cell death in Parkinson’s disease by Jenner (1998)10.1016/S0006-8993(99)01652-2
/ Brain Res. / Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat by Watanabe (1999)10.1161/01.STR.25.4.849
/ Stroke / p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats by Li (1994)10.1016/S0006-8993(97)00524-6
/ Brain Res. / Apoptosis and protein expression after focal cerebral ischemia in rat by Li (1997)10.1038/jcbfm.1994.119
/ J. Cereb. Blood Flow Metab. / Attenuation of p53 expression protects against focal ischemic damage in transgenic mice by Crumrine (1994)10.1152/physrev.1997.77.4.1081
/ Physiol. Rev. / Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives by Mattson (1997)10.1172/JCI118957
/ J. Clin. Invest. / Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice by LaFerla (1996)10.1016/S0891-5849(03)00244-2
/ Free Radic. Biol. Med. / Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis by Tamagno (2003)10.1074/jbc.M212379200
/ J. Biol. Chem. / The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart by Alves da Costa (2003)10.1089/oli.1.1999.9.441
/ Antisense Nucleic Acid Drug Dev. / Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene by Alvarez-Salas (1999)10.1046/j.1471-4159.2001.t01-1-00220.x
/ J. Neurochem. / A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults and amyloid beta-peptide by Culmsee (2001)10.1523/JNEUROSCI.16-04-01337.1996
/ J. Neurosci. / Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death by Morrison (1996)10.1523/JNEUROSCI.18-04-01363.1998
/ J. Neurosci. / Bax involvement in p53-mediated neuronal cell death by Xiang (1998)10.1016/S0169-328X(99)00186-2
/ Brain Res. Mol. Brain Res. / Roles of p53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor by Liu (1999)10.1385/NMM:3:3:159
/ Neuromol. Med. / p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults by Gilman (2003)10.1016/j.neulet.2003.10.048
/ Neurosci. Lett. / p53-mediated mitochondrial dysfunction by proteasome inhibition in dopaminergic SH-SY5Y cells by Nakaso (2004)10.1002/ana.10350
/ Ann. Neurol. / p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism by Duan (2002)10.1016/S0169-328X(99)00146-1
/ Brain Res. Mol. Brain Res. / Activation of p53 and its target genes p21(WAF1/Cip1) and PAG608/Wig-1 in ischemic preconditioning by Tomasevic (1999)10.1046/j.1460-9568.1999.00485.x
/ Eur. J. Neurosci. / ZFM1/SF1 mRNA in rat and gerbil brain after global ischaemia by Covini (1999)10.1016/S0306-4522(98)00484-9
/ Neuroscience / The tumor suppressor p53 and its response gene p21WAF1/Cip1 are not markers of neuronal death following transient global cerebral ischemia by Tomasevic (1999)10.1023/A:1011335525219
/ Apoptosis / Progressively developed myocardial apoptotic cell death during late phase of reperfusion by Zhao (2001)10.1016/S0014-5793(00)02174-8
/ FEBS Lett. / Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors by Maulik (2000)10.1016/j.expneurol.2004.01.030
/ Exp. Neurol. / The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin-alpha by Leker (2004)10.1021/jm020044d
/ J. Med. Chem. / Novel p53 inactivators with neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives by Zhu (2002)10.1101/gad.969302
/ Genes Dev. / Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis by Pani (2002)10.1016/S0014-5793(03)01260-2
/ FEBS Lett. / p53 down-regulation: a new molecular mechanism involved in ischaemic preconditioning by Mocanu (2003)10.1111/j.1523-1755.2004.761_7.x
/ Kidney Int. / Apoptosis in ischemic renal injury: roles of GTP depletion and p53 by Dagher (2004)10.1097/01.ASN.0000040596.23073.01
/ J. Am. Soc. Nephrol. / P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor by Kelly (2003){'key': '10.1016/j.bbrc.2005.03.153_bib82', 'first-page': '41', 'article-title': 'Pifithrin-alpha (PFT-alpha) caused differential protection of rat liver cells and HepG2 cell line in response to the selective cytotoxicity of arsenic and cadmium', 'volume': '38', 'author': 'Begum', 'year': '2002', 'journal-title': 'Biomed. Sci. Instrum.'}
/ Biomed. Sci. Instrum. / Pifithrin-alpha (PFT-alpha) caused differential protection of rat liver cells and HepG2 cell line in response to the selective cytotoxicity of arsenic and cadmium by Begum (2002)10.1096/fj.02-0774com
/ FASEB J. / Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death by Schafer (2003)10.1002/hep.20243
/ Hepatology / Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis by El-Gibaly (2004)10.1097/01.LAB.0000024363.37866.45
/ Lab. Invest. / Acceleration of cutaneous wound healing by transient p53 inhibition by Vollmar (2002){'key': '10.1016/j.bbrc.2005.03.153_bib86', 'first-page': '327', 'article-title': 'p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent', 'volume': '61', 'author': 'Kemp', 'year': '2001', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent by Kemp (2001)10.1016/j.toxlet.2003.11.005
/ Toxicol. Lett. / Influence of altered apoptosis in human lymphoblastoid cell lines on micronucleus frequency by Vukicevic (2004){'key': '10.1016/j.bbrc.2005.03.153_bib88', 'first-page': '149', 'article-title': 'Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines', 'volume': '152', 'author': 'Kanno', 'year': '2004', 'journal-title': 'Toxicol. Lett.'}
/ Toxicol. Lett. / Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines by Kanno (2004)10.1002/ijc.11312
/ Int. J. Cancer / Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin by Pecere (2003)10.1158/1535-7163.877.3.7
/ Mol. Cancer Ther. / Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells by Jiang (2004)10.1023/A:1014422101452
/ Breast Cancer Res. Treat. / Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells by Toillon (2002)10.1016/j.abb.2004.01.004
/ Arch. Biochem. Biophys. / Differential regulation of signal transduction pathways in wild type and mutated p53 breast cancer epithelial cells by copper and zinc by Ostrakhovitch (2004)10.1074/jbc.M211580200
/ J. Biol. Chem. / Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation by Paitel (2003)10.1016/S1568-7864(03)00088-0
/ DNA Repair (Amst) / Inhibition of p53, p21 and Bax by pifithrin-alpha does not affect UV induced apoptotic response in CS-B cells by ProiettiDe Santis (2003)10.1242/jcs.114.24.4621
/ J. Cell Sci. / Regulation of functional nuclear pore size in fibroblasts by Feldherr (2001)10.1084/jem.20031216
/ J. Exp. Med. / NF-kappaB and p53 are the dominant apoptosis-inducing transcription factors elicited by the HIV-1 envelope by Perfettini (2004)10.1074/jbc.C300011200
/ J. Biol. Chem. / p53 inhibitor PFT-alpha can suppress heat shock and glucocorticoid signaling pathways by Komarova (2003)10.1074/jbc.M403539200
/ J. Biol. Chem. / Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation by Murphy (2004)10.1523/JNEUROSCI.23-24-08586.2003
/ J. Neurosci. / Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons by Culmsee (2003)10.1074/jbc.M312135200
/ J. Biol. Chem. / Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress by Nair (2004)10.1093/emboj/cdg157
/ EMBO J. / p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner by Gorgoulis (2003)10.1038/sj.onc.1207346
/ Oncogene / Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines by Cronauer (2004)10.1210/en.2004-0253
/ Endocrinology / Regulation of steroidogenesis by p53 in macaque granulosa cells and H295R human adrenocortical cells by Cherian-Shaw (2004)10.1186/1471-2199-4-9
/ BMC Mol. Biol. / The p53-inhibitor pifithrin-alpha inhibits firefly luciferase activity in vivo and in vitro by Rocha (2003)10.1038/356215a0
/ Nature / Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours by Donehower (1992)10.1016/S0960-9822(00)00002-6
/ Curr. Biol. / Tumor spectrum analysis in p53-mutant mice by Jacks (1994)10.1016/S0027-5107(01)00273-1
/ Mutat Res. / Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro by Bassi (2002)10.1016/S1097-2765(03)00050-9
/ Mol. Cell / p53 has a direct apoptogenic role at the mitochondria by Mihara (2003)10.1038/sj.cdd.4401180
/ Cell Death Differ. / p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation by Schuler (2003)10.1016/S1535-6108(03)00244-7
/ Cancer Cell / Puma is an essential mediator of p53-dependent and -independent apoptotic pathways by Jeffers (2003)10.1002/jnr.10822
/ J. Neurosci. Res. / Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die by Bonini (2004)
Dates
Type | When |
---|---|
Created | 20 years, 4 months ago (April 11, 2005, 4:03 p.m.) |
Deposited | 2 years, 3 months ago (May 2, 2023, 5:47 p.m.) |
Indexed | 3 days, 3 hours ago (Aug. 23, 2025, 9:55 p.m.) |
Issued | 20 years, 2 months ago (June 1, 2005) |
Published | 20 years, 2 months ago (June 1, 2005) |
Published Print | 20 years, 2 months ago (June 1, 2005) |
@article{Gudkov_2005, title={Prospective therapeutic applications of p53 inhibitors}, volume={331}, ISSN={0006-291X}, url={http://dx.doi.org/10.1016/j.bbrc.2005.03.153}, DOI={10.1016/j.bbrc.2005.03.153}, number={3}, journal={Biochemical and Biophysical Research Communications}, publisher={Elsevier BV}, author={Gudkov, Andrei V. and Komarova, Elena A.}, year={2005}, month=jun, pages={726–736} }